Avrupa Birliği - Hırvatça - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hipertenzija, plućna - Гипотензивные, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Avrupa Birliği - Hırvatça - EMA (European Medicines Agency)

bayer ag - rivaroksaban - arthroplasty, replacement; venous thromboembolism - antitrombotska sredstva - xarelto, uvedene zajedno sa ацетилсалициловой kiselinom (ask) sami ili sa asc plus клопидогрел ili Тиклопидин, prikazana za prevenciju атеротромботических događaja kod odraslih pacijenata nakon akutnog koronarni sindrom (acs) s povišenom razinom кардиальных biomarkera. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. prevencija venske tromboembolije (vte) u odraslih bolesnika koji se podvrgavaju izborni operacije zamjena kuka ili koljena. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Avrupa Birliği - Hırvatça - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

medis adria d.o.o., kolarova 7, zagreb, hrvatska - metforminklorid - filmom obložena tableta - 1000 mg - urbroj: jedna filmom obložena tableta sadrži 1000 mg metforminklorida, što odgovara 780 mg metformina

Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

medis adria d.o.o., kolarova 7, zagreb, hrvatska - metforminklorid - filmom obložena tableta - 500 mg - urbroj: jedna filmom obložena tableta sadrži 500 mg metforminklorida, što odgovara 390 mg metformina

Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

medis adria d.o.o., buzinska cesta 58, zagreb, hrvatska - metforminklorid - filmom obložena tableta - 850 mg - urbroj: jedna filmom obložena tableta sadrži 850 mg metforminklorida, što odgovara 662, 9 mg metformina

Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

jadran galenski laboratorij d.d., svilno 20, rijeka - amlodipinum - tableta - 10 mg - urbroj: jedna tableta sadrži 10 mg amlodipina u obliku amlodipinbestilata

Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

jadran galenski laboratorij d.d., svilno 20, rijeka - amlodipinum - tableta - 5 mg - urbroj: jedna tableta sadrži 5 mg amlodipina u obliku amlodipinbesilata

Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

mylan hrvatska d.o.o., koranska 2, zagreb, hrvatska - kiselina mycophenolicum - filmom obložena tableta - 500 mg - urbroj: jedna filmom obložena tableta sadrži 500 mg mofetilmikofenolata

Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - oksazepam - tableta - 10 mg - urbroj: 1 tableta sadrži 10 mg oksazepama